Healthcare / Health Information ServicesASX
$4.79
-0.16 (-3.23%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-15.4M · quality 70.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$767M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-77.1%
↓Gross Margin
100.0%
↑Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-51907.1%
FCF / Net income
0.89x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $28000.0 · net income $-16.4M · FCF $-14.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $28000.00 | $28000.00 | — | — | — |
| Net Income | $-16.4M | $-16.4M | $-14.0M | $-11.1M | $-17.2M |
| EBITDA | $-20.9M | $-20.9M | $-16.1M | $-11.9M | $-16.4M |
| EPS | -0.18 | -0.18 | -0.18 | -0.14 | -0.26 |
| Gross Margin | 100.0% | 100.0% | — | — | — |
| Operating Margin | -78864.3% | -78864.3% | — | — | — |
| Net Margin | -58592.9% | -58592.9% | — | — | — |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.06 | 0.04 | 0.03 |
| Current Ratio | 37.11 | 37.11 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-14.5M | $-14.5M | $-15.4M | $-15.7M | $-16.0M |
| Returns | |||||
| ROE | -77.1% | -77.1% | -83.3% | -36.4% | -42.2% |
| Valuation | |||||
| P/B | 20.77 | 20.77 | 1.12 | 0.62 | 1.38 |
| Growth & Yield | |||||
| EPS Growth | 0.2% | 0.2% | -25.3% | 45.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+574.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.18 → -0.18
Residual
+574.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.